Archive for the ‘Treatment’ Category

Ivermectin’s Accidental Breakthrough: Parkinson’s & Alzheimer’s

https://choiceclips.whatfinger.com/2025/10/11/ivermectins-accidental-breakthrough-a-lifeline-for-parkinsons-and-alzheimers-sufferers/

Ivermectin’s Accidental Breakthrough: A Lifeline for Parkinson’s and Alzheimer’s Sufferers

A stunning revelation from the front lines of medicine. Dr. William Makis is reporting unprecedented success using ivermectin for two of our most devastating neurological conditions: Parkinson’s and Alzheimer’s disease. His accidental discovery is yielding results that defy conventional expectations. For Parkinson’s, high-dose ivermectin (60-72mg) is facilitating remarkable recoveries. Patients on maximum standard treatments, once barely mobile, are now experiencing dramatic improvements in movement and symptoms. One such patient, after a few weeks of treatment, returned to playing golf—an activity lost for years. The outcomes in Alzheimer’s are even more profound.

Dr. Makis details how family members, following his protocol of low-dose ivermectin (12-24mg for a few days), are witnessing what can only be described as medical miracles. Loved ones who had not recognized family members for years are suddenly reconnecting. Memories are flooding back; cognitive abilities are being restored. In one extraordinary case, a patient was taken off hospice after their condition improved so drastically. The stories are heart-rending: “My grandma’s back.” Families are reclaiming precious time with loved ones they felt they had lost forever. All from a few pills of a medication with a well-established safety profile.

Dr. Makis challenges the medical establishment, noting that supportive preclinical research on ivermectin and Alzheimer’s appears to have been scrubbed from mainstream search engines, a silent testament to the battle over this repurposed drug. He urges the public to look at the evidence he shares on his platforms. The potential for a safe, accessible, and effective treatment for these neurodegenerative scourges is too significant to ignore.

(See link for article, video, dosages, and links to testimonials)

______________

For more on Parkinson’s:

Alzheimer’s:

Ivermectin:

Category:

Activism, Alzheimer's, Treatment

Nicotine – Not What You Think

Nicotine: Friend or Foe?

For decades we’ve been told that nicotine is as addictive as heroine, cocaine, amphetamines and alcohol, but a 2015 Harvard study  confirmed nicotine alone is not addictive.  The true perps are the added pyrazines, acetaldehyde, anabasine, nornicotine, anatabine, cotinine, and myosomine. These addictive derivatives potentiate 5-HT binding to receptors in the CNS which results in enhanced dopamine release independently of nicotine.

People have a hard time separating nicotine from cigarettes and chewing tobacco, which ARE laden with cancer causing chemicals and addictive substances.  But they are not one and the same.

The FDA still allows the tobacco industry to add 599 different man-made chemicals, of which 15 are pyrazines, to tobacco products causing the known damage from cigarettes and other tobacco products. This corrupt agency has been involved in a 30 year coverup regarding the incredible healing powers of nicotine and is currently in the process of attempting to reduce nicotine in cigarettes – not the actual harmful substances.

Read on to discover the many healthy attributes of nicotine…..

https://www.psychologytoday.com/us/blog/the-leading-edge/202506/the-hidden-healing-power-of-nicotine

The Hidden Healing Power of Nicotine

From sacred plant to modern medicine.

By Mitchell B. Liester M.D.

Updated June 8, 2025 |  Reviewed by Kaja Perina

Key points

  • Indigenous peoples use tobacco ceremonially for healing, unlike today’s addictive commercial products.
  • Nicotine activates brain receptors that protect neurons and reduce inflammation.
  • Nicotine shows therapeutic promise for depression, ADHD, Tourette’s, and schizophrenia.
  • Research validates ancient wisdom: Nicotine’s anti-inflammatory effects may treat multiple brain disorders. (See link for article)
  • Nicotine has shown effectiveness in treating MS, autism, and certain cancers.
  • Nicotine is also a potential candidate for treating ulcerative colitis, IBD, rheumatoid arthritis, osteoarthritis, multiple sclerosis, and myocarditis.
  • Nicotine is considered the most reliable cognitive enhancer that we currently have.
  • A 2010 meta‑analysis of 41 double‑blind, placebo‑controlled trials confirmed significant improvements in alerting and orienting attention as well as memory tasks following nicotine administration. As mentioned above, nicotine selectively activates nicotinic acetylcholine receptors (nAChRs), particularly those containing the α4β2 and α7 subunits, which in turn modulate dopamine, glutamate, serotonin, gamma-aminobutyric acid (GABA), and acetylcholine pathways associated with enhanced cognitive processing.
  • Nicotine affects the adaptive immune system, influencing T cell differentiation and function. This could influence how the body recognizes and eliminates infected cells, affecting COVID-19 progression and severity.

Nicotine is Considered a Nutrient by Some

Nicotine is a naturally occurring organic alkaloid compound, not a man-made chemical. It is present in all the nightshade vegetables as well as egg plant/aubergine, potatoes, tomatoes, celery, cauliflower, and the tobacco plant.

Many tissues in the human body have nicotine receptors including in the brain. Nicotine is an energizer that makes cells work better.

On average, a person absorbs 1-1.5mg of nicotine from a single cigarette.  Potatoes contain about 15 mg of solanine, the glycoalkaloid structurally similar to nicotine – which is roughly the equivalent of smoking a cigarette.  

If nicotine alone was addictive, then we would be inundated with folks addicted to cauliflower, tomatoes, potatoes, and other vegetables.  Sadly, this is far from the case.

Nicotine Benefits

Nicotine has been found to help with neurological disorders like Parkinsons and Alzheimers, as well as with Myocarditis, tinnitus, long covid, and mild cognitive impairment. 

Nicotine and COVID

Recently, Dr. Bryan Ardis has stated that not only is nicotine not addictive, research shows smokers have lower COVID infection rates.  In 2020, French researchers isolated the spike protein genes which are identical to the toxins from snakes of the Ophiophagus (cobra) and Bungarus genera. The benefits of nicotine in the smokers’ bodies was protecting the nicotine receptors from allowing venom spike proteins from binding to the nACHR receptors. The authors acknowledge that ivermectin was successful for the same reason.

No one in their right might would recommend smoking cigarettes, but again, don’t conflate nicotine with cigarettes.

The authors suggest nicotine as a potential preventative against COVID infection as both the epidemiological/clinical evidence and the in silico findings suggest that COVID is a nAChR disease that could be prevented and controlled by nicotine as it competes with the SARS-CoV-2 binding to the nAChR. Other research has also suggested nicotine as a COVID treatment.

In 2023 the NIH funded and published a study confirming that the venomous spike proteins of COVID target alpha-7 nicotinic acetylcholine receptors (not ACE2 receptors).

Then in the same year, a study was published of 4 case studies of long-haul COVID patients and their miraculous recovery in only 6 days of using 7mg nicotine patches.  The authors state:

The transcutaneous administration of nicotine ensures constant serum levels without peak levels.  Thus, we did not see any development of nicotine dependence in the context of nicotine patch therapy.  From the author’s point of view, this is not be be expected.

Others have found that there doesn’t seem to be any abuse liability whatsoever in taking nicotine by patch in nonsmokers. 

Go here for an article on how nicotine patches are made as well as what raw materials are used in them.  Some patches may use pure nicotine or mixed with entities such as hydrochloride, dihydrochloride, sulfate, tartrate, bitartarate, zinc chloride, and salicylate to form derivatives.  A carrier layer is made from a variety of plastics as well as a occlusive backing layer, adhesive such as acrylate ester/vinyl pyrrolidone copolymers, dimethyl silicone polymers, and acrylate polymers.  Other ingredients, such as pigments, dyes, inert fillers, and processing aids, may be mixed in with the drug. Certain types of patches also include permeation enhancers to improve drug penetration and some contain anti-itch agents like bisabolol, oil of chamomile, chamazulene, allantoin, D-panthenol, glycyrrhetenic acid, corticosteroids, and antihistamines.

Dr. Merritt also recommends nicotine for COVID and has developed treatment protocols:   https://drleemerritt.com/media/Protocol_early_COVID_Treatment._2_Rev_5-5-22.pdf

http://  Approx. 3 Min

Nicotine Benefits

Dr. Lee Merritt

12/24

Dr. Merritt gives examples of how nicotine gum immediately helped numerous patients.

Click Dr Bryan Ardis to hear more.   And here for his slide show on nicotine which is quite informative.

In this video, Ardis recommends starting low and slow on TOLEVITA brand nicotine patches, which uses a natural nicotine extract.  He recommends starting with 1mg daily and over time, depending upon how you feel to titrate up to 3mg.  He takes 7mg but only after being on lower dosages for 4 years. 

He also discusses how historically nicotine has been used for cancer, and to remit neurodegenerative diseases, etc.  A study used 15mg nicotine patches for 6 months showed improvement for 100% of patients with early dementia.  They were all contacted after stopping the study and NO patients were still using it and NO patients struggled with any addictive behaviors from using it.  (We’ve been lied to again, friends)

The following information is for educational purposes only and not meant to diagnose and treat.  Make sure to discuss any and all treatments with your health practitioner.

Directions for using nicotine patches:

Preventative
  • Purchase 14mg size Nicotine Patches and cut into 6 equal pieces and wear one small size patch daily, on rib cage or upper arm.  (This is what Dr. Ardis does daily since November of 2022 to prevent all future virus/venoms or variant exposures).
Long-Hauler COVID Sufferers
  • Purchase and wear one 7 mg Nicotine Patch daily for 1 week minimum and then continue until symptoms abate. Go here to read one person’s successful usage of 7mg nicotine patch for Long COVID.
C19 Vaccine Injured
  • Follow Long-Hauler COVID protocol above.

Directions to use Nicotine Gum

Preventative
  • Purchase 2mg size Nicotine Gum and chew 1 gum tablet for at least 10 minutes, twice a day.  (This is what Dr. Ardis’s wife Jayne does daily to prevent all future virus/venoms or
    variant exposures).
Long-Hauler COVID Sufferers
  • Purchase 2mg Nicotine Gum (do NOT buy 4mg nicotine gum), and chew one 2 mg gum tablet for 10 minutes, 4 times per day for 2 weeks or until symptoms resolve and then continue until symptoms abate.
C19 Vaccine Injured
  • Follow Long-Hauler COVID protocol above.

According to Ardis there are nicotine receptors in the gut and a few people when chewing and swallowing nicotine gum get nauseous and vomit or get loose stools. He states this is because so much of the venom spike proteins are attached to the nicotine receptors that line the bowel that when nicotine is present the massive amount of venom in the bowel gets released, and the body is created to expel poisons.  If this is a problem for you, switch to nicotine patches which by pass the bowels. Nicotine from patches are absorbed into your blood stream via the skin in less than 30 seconds.

He also mentioned getting organic tobacco leaf and then boiling the leaves and soaking the feet for 20-30 min several times a week.

He recommends Rugby brand patches and gum (2mg) as well as LUCY gum (2mg).

Category:

Activism, Herbs, Treatment

Revolving Door Strikes Again

https://www.midwesterndoctor.com/p/the-revolving-door-strikes-again?

The Revolving Door Strikes Again

Why did the FDA relentlessly suppress all evidence of vaccine injuries?

A Midwestern Doctor
Oct 08, 2025

Many individuals I’ve spoken to believe Peter Marks is the government official most directly responsible for the entire COVID catastrophe, and those I know who directly interacted with him despise him. For that reason, six months ago, I published a detailed exposé of his conduct throughout the pandemic, both to highlight the systemic issues within our healthcare bureaucracy that must be fixed and to disincentivize other health officials from following in his footsteps. Since that time:

•Despite immense industry pushback, he was replaced with MAHA appointee Vinay Prasad

•Marks has made statements on the national media which display either a profound degree of ignorance of vaccines or a cult-like devotion to them, such as telling CBS the MMR vaccine absolutely does not cause encephalitis—despite this specific injury being one of the only vaccine injuries the Federal Government acknowledged as real and eligible for compensation when it created the the National Childhood Vaccine Injury Act of 1986.

Note: the primary reason DMSO (a safe and affordable substance with remarkable therapeutic applications against a wide range of “incurable” ailments) never entered mainstream medical practice was because the FDA, feeling DMSO’s broad therapeutic potential threatened their control of American medicine, waged a multi-decade war against it despite widespread opposition from the public, Congressmen, scientists and physicians across the country. One journalist who interviewed the successive FDA commissioners throughout this saga was struck by how “lacking [they were] in solid information about the most spectacular and controversial drug of our time” and how often they simply quoted nonsensical misinformation the FDA had previously put out about the drug without a basic understanding of it—something I would argue also applies to Peter Marks.

•Yesterday, it was announced that Peter Marks had started working with Eli Lilly, where he will oversee molecule discovery and infectious diseases at Lilly. While his salary has not been publicly announced, the AI systems I queried said given the existing precedent, he would likely get 2-6 million this year (a big upgrade from his roughly $200,000.00 FDA salary)—and possibly much more (e.g. 10-15 million).

This understandably enraged the vaccine injured parties who directly interacted with Marks over the last four years, so I felt it was important to revisit exactly what Marks did and discuss the broader revolving door in regulatory medicine.

Note: last year, the FDA approved Eli Lilly’s anti-amyloid monoclonal antibody for the treatment of Alzheimer’s disease (granting the application Fast Track, Priority Review, and Breakthrough Therapy designations). I showed in last weekend’s article, that these costly drugs do close to nothing (they may slightly slow the progression of Alzheimer’s disease) while simultaneously creating a variety of severe symptoms including giving over a quarter of recipients brain bleeds and brain swelling—yet remarkably, safer and much more effective Alzhemier’s therapies have languished in obscurity. (See link for article)

______________

**Comment**

I’m with Rodney Dangerfield on TOBAL,

“There Oughta be a law!”

For more:

Category:

Activism, Treatment, vaccines

ACTION: Stop Hemp Ban!

https://anh-usa.org/stop-the-hemp-ban-now/

Stop the Hemp Ban Now!

By The ANH Team 
Stop the Hemp Ban Now!

A dangerous provision has been included in a Congressional spending bill that could spell the end of your access to full-spectrum hemp products. Action Alert!

Listen to the audio version of this article:

THE TOPLINE

  • A provision in the House Agriculture Appropriations Subcommittee’s FY 2026 spending bill would ban all ingestible hemp products containing “quantifiable amounts” of THC or THC-like cannabinoids—effectively outlawing many CBD and full-spectrum hemp oils that contain small, non-psychoactive amounts of THC.
  • While the measure is framed as targeting unregulated, intoxicating products like delta-8, it goes far beyond that by threatening the entire hemp industry and cutting off consumer access to safe, beneficial full-spectrum hemp products.
  • The provision still faces hurdles, including reconciliation with the Senate version of the bill and ongoing political uncertainty, but urgent grassroots opposition is needed to prevent it from becoming law.

If you rely on hemp, CBD, or full-spectrum hemp oil to support your health, listen up!

A dangerous provision buried in a House spending bill threatens to ban most of the hemp products currently available on the market. Just as research continues to confirm the remarkable healing potential of hemp and CBD—showing their impact on the body’s endocannabinoid system, which influences everything from mood to immunity—some in Congress are moving to strip away our access. We must raise strong grassroots opposition to stop this misguided policy.

The House Agriculture Appropriations Subcommittee’s spending bill for FY 2026 contains a deeply troubling provision that effectively bans the production and sale of all hemp-derived products that contain “quantifiable amounts” of THC (one of the psychoactive components of hemp that provides the “high”) or cannabinoids with similar, THC-like effects. What “quantifiable amounts” means specifically is to be determined later by regulators.

Put in plain terms, this would ban all ingestible hemp products with any level of THC in them. This means that many CBD oil and full-spectrum hemp oil products would suddenly become illegal.

The goal of the amendment is to close a loophole created by the previous Farm Bill that has allowed unregulated, intoxicating hemp products on the market. Recall that the 2018 Farm Bill legalized hemp at the federal level, defining it as a cannabis plant with less than 0.3 percent THC. In the six years since that bill became law, some companies found a way to stay within the guardrails put in place by the new law but still be able to chemically synthesize psychoactive or intoxicating products from legal hemp plants. These products include members of the THC family like delta-8 and delta-10. Delta-8 occurs naturally in the hemp plant at miniscule levels, but higher levels of delta-8 THC are produced artificially in the laboratory by chemically converting CBD through a process called isomerization.

While the merits of cracking down on delta-8 and other products can be debated, what’s crystal clear is that this amendment goes far beyond banning delta-8 and similar products and takes a huge swipe at the hemp industry as a whole without any justification.

Some of the best and healthiest products are full-spectrum hemp oils that contain all of the nearly 500 known compounds known to be present in hemp, including cannabinoids (>60), terpenes (>140), and fatty acids that occur naturally in the plant. Among this morass of compounds are tiny, non-psychoactive amounts of THC. The real benefits of hemp come from the “entourage effect” of all these different chemicals acting together. For example, a 2015 study found that highly purified CBD was somewhat effective in treating inflammation and anxiety in mice, but was substantially more effective when the CBD was present in a full spectrum extract because it benefits from the synergy from the full entourage of typically associated compounds.

Banning, in one fell swoop, all hemp products with “quantifiable amounts” of THC is the very definition of throwing the baby out with the bath water and will take vital products out of our medicine cabinets.

Remember, too, that is not the only threat to CBD access. Because CBD has been approved as a drug, the FDA maintains that it cannot be a supplement, though the agency appears only to be going after CBD companies making illegal disease claims. The agency has said that it believes a new regulatory pathway is needed to deal with CBD. Whatever that pathway is, you can bet the agency will do its best to protect drug industry profits by making it next to impossible to have affordable CBD supplements.

There are still a number of hurdles before this can ever become law. Similar language was added to the Senate version of this bill, but Senator Rand Paul (R-KY) was able to remove it. House and Senate versions of the bill would need to be further negotiated and reconciled before being sent to the President for approval. The possibility of a government shutdown in the coming weeks further complicates matters.

There is no time to lose. We must oppose this terrible policy and kill it before the bill moves any further.

Action Alert!

(Go to top link for sign petition)

_______________

**Comment**

CBD oil has been a game changer for me and my husband.  It helps us sleep much more soundly.

It has come under attack before, with the FDA misleading the public on its safety.  CBD is one of the most well researched non-psychoactive cannabinoids and it has an incredible array of health benefits, with evidence showing that has profound anti-inflammatory and immune modulating effects and can help with pain, anxiety, depression, certain cancers, and even heart health.

Funny how the ‘the powers that be’ always seem mostly concerned with safe, inexpensive, effective products, but are completely blind, deaf, and dumb to unsafe, expensive, and ineffective ‘vaccines’ and drugs.

I’m sure the goal is to ban this so we are all forced to use something Big Pharma greatly profits from.

Category:

Activism, Herbs, Supplements, Treatment

SOT For Lyme: Experimental, Expensive, but Full of Potential

https://www.lymedisease.org/sot-lyme-treatment/

SOT therapy for Lyme is experimental, expensive—and full of potential.

Oct. 3, 2025

Part One of a two-part series.

By Maria Marian, ND, MSE

For many people facing chronic infections such as Lyme disease, Epstein–Barr virus (EBV), herpes simplex virus (HSV-1 and HSV-2), or cytomegalovirus (CMV), the journey can be long and frustrating.

Antibiotics, antivirals, herbal therapies, and IV treatments may help initially, yet symptoms often persist or recur. This has led both patients and clinicians to explore innovative therapies that move beyond conventional antimicrobial approaches.

One such emerging option is Supportive Oligonucleotide Therapy (SOT), also referred to as antisense oligonucleotide therapy. Although still considered experimental in the context of Lyme and chronic viral infections, SOT builds upon decades of genetic medicine research and has even reached FDA approval in select infectious and cancer-related applications.

What is SOT?

At its core, SOT is a gene-silencing technique. Scientists design a short synthetic strand of nucleic acid (called an oligonucleotide) that binds to a very specific piece of genetic code inside the pathogen—such as Borrelia burgdorferi (the bacterium that causes Lyme disease) or EBV.

When this oligonucleotide binds, it blocks the pathogen’s ability to produce a protein essential for replication or metabolism. In simple terms, it’s like removing a crucial page from the pathogen’s instruction manual. Without that instruction, the organism can’t replicate efficiently, and its numbers gradually decline.

This strategy falls under the larger field of “antisense therapy.” The term comes from the fact that these therapeutic molecules bind to the “sense” strand of RNA or DNA, neutralizing its ability to produce proteins.

Reference: Crooke ST. Antisense Drug Technology: Principles, Strategies, and Applications. CRC Press; 2008.

How the therapy works

The process of SOT treatment involves several carefully orchestrated steps:

  1. Blood Draw & Testing – A blood sample is taken and analyzed using molecular techniques such as PCR to identify which pathogens are active.
  2. Custom Design – A laboratory designs a patient-specific oligonucleotide tailored to silence a genetic target in that pathogen. Newer approaches like QRE-strain technology (Quasispecies Resistant Engineered strain) aim to account for genetic variations in pathogens, ensuring the oligonucleotide is effective across slightly different strains.
  3. Infusion – Once prepared, the oligonucleotide solution is returned to the clinic and administered as a single intravenous infusion.
  4. Ongoing Action – Unlike antibiotics or antivirals that are metabolized quickly, SOT molecules remain active for months (often up to six months), continuously working “day and night” to suppress pathogen replication.

The Science Behind It

Antisense oligonucleotides are not a new idea. In fact, the first FDA-approved antisense therapy, fomivirsen (Vitravene), was approved in 1998 to treat CMV retinitis in immunocompromised patients【PMID: 9815174】. Since then, several antisense and RNA-based drugs have reached the market for conditions ranging from high cholesterol (mipomersen) to spinal muscular atrophy (nusinersen)【PMID: 29191460】.

In infectious disease specifically:

  • CMV: Fomivirsen demonstrated that gene-silencing therapy can effectively reduce viral activity in humans.
  • Herpesviruses: Preclinical studies have shown that antisense molecules can block HSV and EBV replication in vitro【PMID: 19920191】.
  • Lyme disease: Pilot clinical data suggest that one or two SOT infusions can lead to statistically significant reductions in Borrelia burgdorferi DNA levels detected by PCR. For viral infections, two or three treatments may be needed to achieve measurable decreases.

While more research is essential, these early findings provide a rationale for SOT as a potential adjunctive therapy in chronic infections where other approaches fall short.

Why patients are interested

For individuals struggling with persistent infections, SOT offers several appealing features:

  • Precision targeting: Instead of broadly killing microbes (as antibiotics do), SOT goes after one critical genetic sequence, leaving other microbes untouched.
  • Durability: A single infusion provides months of activity, reducing the need for daily medication.
  • Immune-independent mechanism: Because SOT directly silences genes, it doesn’t rely on the immune system’s strength—a key advantage for patients with immune dysfunction.
  • Potential synergy: Many clinicians use SOT alongside integrative therapies (nutrition, detoxification, antimicrobials) for a more comprehensive approach.

Current limitations

Despite the excitement, it’s important to emphasize what SOT is not at this stage:

  • It is not FDA-approved for Lyme disease, EBV, or HSV. Its only infectious disease approval was for CMV retinitis, and that drug is no longer commercially available.
  • Clinical research in Lyme and chronic viral infections is preliminary, mostly limited to small pilot studies and case reports.
  • Costs can be significant, and insurance rarely covers it.
  • The decline in pathogen burden is gradual, and multiple treatments may be required.

In short: SOT is promising, but it remains an emerging therapy.

Looking ahead with both hope and caution

The field of RNA medicine is growing rapidly, with antisense oligonucleotides, small interfering RNAs (siRNAs), and messenger RNA (mRNA) therapies transforming the landscape of medicine. With continued research, we may see gene-silencing strategies like SOT become mainstream tools in the fight against chronic infections.

For now, patients and clinicians should approach SOT with both hope and caution—hope that it represents a real step forward in treating persistent pathogens, and caution because large, peer-reviewed trials are still needed to fully establish safety, efficacy, and long-term outcomes.

Part two will be published next week.

Maria Marian, ND, MSE, is a naturopathic physician at Jyzen Wellness in Mill Valley, California. In addition to her Doctorate of Naturopathic Medicine, she holds both a Bachelor and Master of Science in Chemical Engineering. She specializes in complex chronic illness, Lyme disease, and integrative approaches to immune dysfunction. Follow her on Instagram: @dr.marian.nd

For more:

According to both Dr. Ross and Dr. Cameron, it’s still too early to confidently recommend SOT for Lyme/MSIDS.

Category:

Lyme, Treatment, Viruses